Bixiye
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1811 - 1820 ee natiijooyinka 3289
Bixiye
QP26-23 Healthy Rewards Member Incentive Program for all Blue Plus PMAP & MNCare Members
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP45-23 Expansion of SmartChoice Program for Fully Insured Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP46-23 Clarification to Preventive Visit Reimbursement Policy (Bulletin P19-23)
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP36-23 Eligibility Redeterminations for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP37-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP38-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP39-23 Commercial Pharmacy Benefit Exclusion for Lamzede®
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP40-23 MHCP Pharmacy Benefit Exclusion for Lamzede® and Zynyz™
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP41-23 Makena® (hydroxyprogesterone caproate): Drug Approval Withdrawn
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023